Bioinformatics analysis of potential common pathogenic mechanisms for COVID-19 and venous thromboembolism

Ling Zhang1, Jing Qin1, Peiwu Li1

  • 1Department of Emergency Medicine, Lanzhou University Second Hospital, Lanzhou, Gansu, China.

Cytokine
|June 23, 2024
PubMed

Insights

Patients with coronavirus disease 2019 (COVID-19) face higher venous thromboembolism (VTE) risks. This study identified common molecular pathways and eight key genes, offering insights into VTE and COVID-19 pathogenesis.

Area of Science:

  • Molecular biology
  • Genomics
  • Bioinformatics

Background:

  • Coronavirus disease 2019 (COVID-19) patients exhibit elevated venous thromboembolism (VTE) rates.
  • The precise molecular mechanisms linking COVID-19 and VTE remain unclear.
  • Further investigation into these molecular underpinnings is crucial.

Purpose of the Study:

  • To elucidate the molecular mechanisms shared between COVID-19 and VTE.
  • To identify common differentially expressed genes (DEGs) and regulatory networks.
  • To explore potential diagnostic markers for both conditions.

Main Methods:

  • Downloaded and analyzed gene expression profiles for COVID-19 and VTE from the GEO database.
  • Identified common DEGs, performed functional annotation, and constructed protein-protein interaction (PPI) networks.
  • Built transcription factor (TF)-gene and TF-miRNA regulatory networks for hub genes.

Main Results:

  • Identified 42 common DEGs between COVID-19 and VTE.
  • Functional analyses revealed shared biological functions and signaling pathways.
  • Discovered 8 significant hub genes (RSL24D1, RPS17, RPS27, HINT1, COX7C, RPL35, RPL34, NDUFA4) with diagnostic potential.

Conclusions:

  • The study highlights common pathogenic pathways in COVID-19 and VTE.
  • Identified pivotal genes may serve as novel targets for mechanistic research.
  • Findings offer new perspectives for understanding and potentially treating these interconnected conditions.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K